1.
Lancet Haematol
; 8(4): e246-e248, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-1213872
Subject(s)
Antineoplastic Agents/supply & distribution , Health Care Rationing/ethics , Hematologic Neoplasms/drug therapy , Resource Allocation/ethics , Antineoplastic Agents/economics , Clinical Decision-Making , Developing Countries/economics , Health Care Rationing/methods , Humans , Medical Oncology/ethics , Pharmacies/ethics , Pharmacies/organization & administration
2.
J Manag Care Spec Pharm
; 26(8): 945-947, 2020 Aug.
Article
in English
| MEDLINE | ID: covidwho-680316
ABSTRACT
The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients. DISCLOSURES: The authors declare no funding sources nor conflicts of interest.